Sable Offshore Energy Inc. v. Ameron International Corporation et al. – 2013 SCC 37 Sable sued a number of defendants for supplying it with corrosion-resisting paint […]
Re. Patent Application No. 2,344,781, CD 1336 This is an Appeal Board decision regarding patent application number 2,344,781 entitled "Monitoring System for Determining and Communicating a […]
Re. Patent Application No. 2306540, CD 1334 This patent application concerned the tracking of required payments or refunds of value added taxes for mailpieces. The Final […]
Zero Spill Systems (Int’l) Inc. v. 614248 Alberta Ltd. – 2013 FC 616 This action concerns allegations of infringement of two Canadian Patents No. 2,258,064 (064 […]
Karolinska Institutet Innovations AB v. Attorney General of Canada, 2013 FC 715 The Applicant attempted to file a patent application with the Canadian Intellectual Property Office […]
Wyeth v. Abbot Labs (Fed. Cir. 2013) Wyeth appealed from the U.S. District Court for the District of New Jersey’s grant of summary judgment that claims […]
PreMD Inc. v. Ogilvy Renault LLP, 2013 ONCA 412 This appeal and cross-appeal concerned the measure of damages for Ogilvy’s negligence and breach of contract in […]
Safe Gaming Systems Inc. v. Atlantic Lottery Corporation, 2013 FC 217 Before filing their defences to this patent infringement action, the Defendants moved to strike […]
Full text of the government’s response The Honourable Christian Paradis responded on behalf of the Government of Canada to the recommendations made by the Standing Committee […]
Association for Molecular Pathology v Myriad Genetics Inc, US SC No 12–398 (2013) - The US Supreme Court must determined that a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, but cDNA is patent eligible because it is not naturally occurring.
Effective June 10, 2013 PN2013-04 This Practice Notice builds upon the guidance in section 17.02.03 (Medical and surgical methods) of MOPOP and in PN 2013-02 (Examination […]
Teva Canada Limited v. Pfizer Canada Inc. (33951) The Supreme Court has revised its Sildenafil (Viagra) decision (2012 SC 60). The Court granted, in part, Pfizer’s […]
Apotex Inc. v. Abbott Laboratories, 2013 ONSC 2958 Apotex sought equitable disgorgement of profits of Abbott and Takeda, on the ground of unjust enrichment. Specifically, Apotex […]
Bayer Inc. v. Cobalt Pharmaceuticals, 2013 FC 573 Bayer sought an order prohibiting the Minister of Health from issuing a Notice of Compliance (NOC) to Cobalt, […]
Link to the proposed amendments to the Patents Bill. Rather than excluding a computer program from being a patentable invention, the amendments clarify that a computer program […]
Link to full text of the proposed Act. The Patent Quality Improvement Act amends the Leahy-Smith America Invents Act to remove the eight-year sunset provision with respect […]
HTC v. Apple, [2013] EWCA Civ 451 (Court of Appeals of England and Wales) Per Kitchin L.J. (Richards L.J. concurring): This appeal was concerned with […]
Teva Canada Innovation v. Canada (Attorney General), 2013 FC 448 Teva asked the Court to set aside a decision of the Patented Medicine Prices Review Board […]